A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is the first of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
[1] [2] These should be discussed with your prescribing clinician if they are persistent or significantly affecting your quality of life
Phentermine: Common: Increased heart rate, elevated blood pressure, insomnia, anxiety, dry mouth
You are under the close care of a doctor who has determined a short-term stimulant is safe for you
When the researchers compared cartilage from treated and untreated mice, they detected changes in the expression of nearly 8,300 proteins